February 26, 2026

AAO Recap: 3.5-Year Observations from the GATHER2 Open-Label Extension (OLE) Trial

Explore the latest findings from the GATHER2 OLE trial on Avacincaptad Pegol, presented by Dr. Arshad Khanani at AAO, revealing key safety and efficacy insights for geographic atrophy treatment.

The Ophthalmologist

February 24, 2026

Medicontur Premium Class – the global cataract & refractive community

Evidence-based, clinically driven, interactive, and accessible

The Ophthalmologist

February 19, 2026

Toward Better Management of Charles Bonnet Syndrome

Newly published guidance presents a practical guide to managing CBS in busy clinics

The Ophthalmologist

February 18, 2026

4DMT Completes Enrollment in Gene Therapy Trial for Wet AMD

Phase 3 4FRONT-1 study compares 4D-150, an investigational gene therapy, against aflibercept 2 mg in treatment-naïve patients

The Ophthalmologist

February 16, 2026

Dry Eye After Cataract Surgery

Scientific Reports study compares dry eye effects of phacoemulsification and MSICS

The Ophthalmologist

February 09, 2026

Dropless Cataract Surgery: Redefining Postoperative Care

Evidence and UKISCRS guidance supporting dropless cataract surgery in routine practice

The Ophthalmologist

February 06, 2026

Searching for the Spectral Signature of Alzheimer’s

Could a tri-spectral retinal imaging module offer new hopes for Alzheimer’s disease screening?

The Ophthalmologist

February 05, 2026

Uveitis and Inflammation: A Two-Way Risk

New study explores the bi-directional relationship between uveitis and autoimmune & inflammatory diseases

The Ophthalmologist

February 04, 2026

FDA Greenlights Repeat Use of Glaukos’ iDose® TR

Glaukos announces US FDA approval of NDA supplement allowing for re-administration of treatment

The Ophthalmologist